Novo Nordisk and Eli Lilly tumble after Hims & Hers announce $49 copy of Wegovy pill

Weight-loss drugmakers Eli Lilly and Novo Nordisk tumbled after telehealth company Hims & Hers announced Thursday it will offer a copy of the newly launched Wegovy pill for $49, far less than the $149 Novo sells the branded pill for.

Copenhagen-listed shares of Novo dropped as much as 9% on the news, while Eli Lilly stock fell 4% in premarket trading.

Hims & Hers stock soared 15%.

This is a breaking story. Please refresh for updates.